Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Jun-30-21 | Mar-31-21 | Sep-30-20 | Jun-30-20 | Jun-05-20 | Mar-31-20 | Mar-05-20 | Dec-31-19 |
| | 10-Q | 10-Q | 10-Q | 10-Q | 8-K | 10-Q | 8-K | 10-K |
| Revenues |
| Company product sales | | | 89.5 | 93.8 | | 75.0 | | 64.3 |
| Topical | | | 37.0 | 38.3 | | 42.5 | | 46.2 |
| Injectables | | | 12.7 | 15.8 | | 16.4 | | 18.1 |
| Contract manufacturing sales | | | 1.1 | 0.9 | | 1.0 | | 1.4 |
| Research and development services and other income | | | 0.5 | 0.4 | | 0.3 | | 0.2 |
| |
| Mix |
| Company product sales | | | 174.4% | 169.1% | | 124.5% | | 97.6% |
| Topical | | | 72.2% | 69.1% | | 70.6% | | 70.0% |
| Injectables | | | 24.8% | 28.4% | | 27.3% | | 27.5% |
| Contract manufacturing sales | | | 2.1% | 1.7% | | 1.7% | | 2.1% |
| Research and development services and other income | | | 0.9% | 0.8% | | 0.4% | | 0.4% |
| |
| Growth |
| Company product sales | | | 40.1% | 51.2% | | 27.4% | | 7.9% |
| Topical | | | -15.9% | -7.2% | | 17.3% | | 31.4% |
| Injectables | | | -35.7% | -24.1% | | -27.3% | | -25.9% |
| Contract manufacturing sales | | | -57.2% | -77.8% | | -80.8% | | -77.5% |
| Research and development services and other income | | | 57.8% | 64.8% | | -10.6% | | 7.0% |
|